{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T13:48:14Z","timestamp":1758980894034},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,8,13]],"date-time":"2013-08-13T00:00:00Z","timestamp":1376352000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Prepubertal gynecomastia is a rare condition and most frequently classified as idiopathic. In HIV-infected adults gynecomastia is a recognised but infrequent side-effect of antiretroviral treatment (ART) and mostly attributed to efavirenz use. Gynecomastia should be distinguished from pseudogynecomastia as part of the lipodystrophy syndrome caused by Nucleoside Reverse Transcriptase Inhibitors (NRTIs) to avoid incorrect substitution of drugs. In the medical literature only five cases of prepubertal gynecomastia in children taking ART are described and underlying pathogenesis was unknown. The occurrence of adverse effects of ART may interfere with therapy adherence and long-term prognosis and for that reason requires attention. We report the first case of prepubertal gynecomastia in a young girl attributed to efavirenz use.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Case presentation<\/jats:title>\n            <jats:p>A seven-year-old African girl presented with true gynecomastia four months after initiation on ART (abacavir, lamivudine, efavirenz). History, physical examination and laboratory tests excluded known causes of gynecomastia and efavirenz was considered as the most likely cause. Six weeks after withdrawal of efavirenz the breast enlargement had completely resolved.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Efavirenz-induced gynecomastia may occur in children as well as in adults. With the increasing access to ART, the possibility of efavirenz-exposure and the potential occurrence of its associated side-effects may be high. In resource-poor settings, empirical change from efavirenz to nevirapine may be considered, providing no other known or alarming cause is identified, as efavirenz-induced gynecomastia can resolve quickly after withdrawal of the drug. Timely recognition of gynecomastia as a side-effect of efavirenz is important in order to intervene while the condition may still be reversible, to sustain adherence to ART and to maintain the sociopsychological health of the child.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2431-13-120","type":"journal-article","created":{"date-parts":[[2013,8,13]],"date-time":"2013-08-13T12:17:38Z","timestamp":1376396258000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Efavirenz-induced gynecomastia in a prepubertal girl with human immunodeficiency virus infection: a case report"],"prefix":"10.1186","volume":"13","author":[{"given":"Mette S","family":"van Ramshorst","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdeline","family":"Kekana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen E","family":"Struthers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James A","family":"McIntyre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Remco PH","family":"Peters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,8,13]]},"reference":[{"key":"852_CR1","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1517\/14740330802442382","volume":"7","author":"A Eckman","year":"2008","unstructured":"Eckman A, Dobs A: Drug-induced gynecomastia. Expert Opin Drug Saf. 2008, 7: 691-702. 10.1517\/14740330802442382.","journal-title":"Expert Opin Drug Saf"},{"key":"852_CR2","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1097\/MOP.0b013e328305e415","volume":"20","author":"NS Ma","year":"2008","unstructured":"Ma NS, Geffner ME: Gynecomastia in prepubertal and pubertal men. Curr Opin Pediatr. 2008, 20: 465-470. 10.1097\/MOP.0b013e328305e415.","journal-title":"Curr Opin Pediatr"},{"key":"852_CR3","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/j.1365-2265.2004.02059.x","volume":"61","author":"R Einav-Bachar","year":"2004","unstructured":"Einav-Bachar R, Phillip M, Aurbach-Klipper Y, Lazar L: Prepubertal gynaecomastia: aetiology, course and outcome. Clin Endocrinol (Oxf). 2004, 61: 55-60. 10.1111\/j.1365-2265.2004.02059.x.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"852_CR4","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1056\/NEJM199302183280708","volume":"328","author":"GD Braunstein","year":"1993","unstructured":"Braunstein GD: Gynecomastia. N Engl J Med. 1993, 328: 490-495. 10.1056\/NEJM199302183280708.","journal-title":"N Engl J Med"},{"key":"852_CR5","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1097\/00126334-200209010-00007","volume":"31","author":"E Bernasconi","year":"2002","unstructured":"Bernasconi E, Boubaker K, Junghans C, Flepp M, Furrer HJ, Haensel A, Hirschel B, Boggian K, Chave JP, Opravil M, Weber R, Rickenbach M, Telenti A, Swiss HIV Cohort Study: Abnormalities of body fat distribution in HIV-infected persons treated with antiretroviral drugs: The Swiss HIV Cohort Study. J Acquir Immune DeficSyndr. 2002, 31: 50-55. 10.1097\/00126334-200209010-00007.","journal-title":"J Acquir Immune DeficSyndr"},{"key":"852_CR6","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/j.1075-122X.2004.21392.x","volume":"10","author":"F Jover","year":"2004","unstructured":"Jover F, Cuadrado JM, Roig P, Rodr\u00edguez M, Andreu L, Merino J: Efavirenz-associated gynecomastia: report of five cases and review of the literature. Breast J. 2004, 10: 244-246. 10.1111\/j.1075-122X.2004.21392.x.","journal-title":"Breast J"},{"key":"852_CR7","first-page":"51","volume":"12","author":"R Manfredi","year":"2004","unstructured":"Manfredi R, Calza L, Chiodo F: Another emerging event occurring during HIV infection treated with any antiretroviral therapy: frequency and role of gynecomastia. Infez Med. 2004, 12: 51-59.","journal-title":"Infez Med"},{"key":"852_CR8","first-page":"404","volume":"9","author":"RZ Li","year":"2007","unstructured":"Li RZ, Xia Z, Lin HH, Wen Y, Wu J, Wang HW: Childhood gynecomastia: a clinical analysis of 240 cases. Zhongguo Dang Dai Er Ke Za Zhi. 2007, 9: 404-406.","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"key":"852_CR9","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.jpag.2006.06.006","volume":"19","author":"NK De Silva","year":"2006","unstructured":"De Silva NK, Brandt ML: Disorders of the breast in children and adolescents, part 1: disorders of growth and infections of the breast. J Pediatr Adolesc Gynecol. 2006, 19: 345-349. 10.1016\/j.jpag.2006.06.006.","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"852_CR10","first-page":"995","volume":"37","author":"J Bass","year":"1991","unstructured":"Bass J, Sochett E: Prepubertal gynecomastia: a cause for concern. Can Fam Physician. 1991, 37: 995-1026.","journal-title":"Can Fam Physician"},{"key":"852_CR11","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1056\/NEJMoa064725","volume":"356","author":"DV Henley","year":"2007","unstructured":"Henley DV, Lipson N, Korach KS, Bloch CA: Prepubertal gynecomastia linked to lavender and tea tree oils. N Engl J Med. 2007, 356: 479-485. 10.1056\/NEJMoa064725.","journal-title":"N Engl J Med"},{"key":"852_CR12","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1517\/14740338.2012.712109","volume":"11","author":"F Deepinder","year":"2012","unstructured":"Deepinder F, Braunstein GD: Drug-induced gynecomastia: an evidence-based review. Exp Opin Drug Saf. 2012, 11: 779-795. 10.1517\/14740338.2012.712109.","journal-title":"Exp Opin Drug Saf"},{"key":"852_CR13","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s00431-011-1546-y","volume":"171","author":"F Ensat","year":"2012","unstructured":"Ensat F, Edelbauer M, Wechselberger G: Unilateral gynecomastia in a prepubertal boy. Eur J Pediatr. 2012, 171: 197-10.1007\/s00431-011-1546-y.","journal-title":"Eur J Pediatr"},{"key":"852_CR14","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1097\/00002030-200202150-00033","volume":"16","author":"NA Qazi","year":"2002","unstructured":"Qazi NA, Morlese JF, King DM, Ahmad RS, Gazzard BG, Nelson MR: Gynaecomastia without lipodystrophy in HIV-1-seropositive patients on efavirenz: an alternative hypothesis. AIDS. 2002, 16: 506-507. 10.1097\/00002030-200202150-00033.","journal-title":"AIDS"},{"key":"852_CR15","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1002\/cncy.20083","volume":"118","author":"P Michelow","year":"2010","unstructured":"Michelow P, Dezube BJ, Pantanowitz L: Fine needle aspiration of breast masses in HIV-infected patients. Cancer Cytopathol. 2010, 118: 218-224. 10.1002\/cncy.20083.","journal-title":"Cancer Cytopathol"},{"issue":"3","key":"852_CR16","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/00126334-200212153-00008","volume":"31","author":"MP Trotta","year":"2002","unstructured":"Trotta MP, Ammassari A, Melzi S, Zaccarelli M, Ladisa N, Sighinolfi L, Mura MS, d\u2019Arminio Monforte A, Antinori A, AdICoNA Study Group: Treatment-related factors and highly active antiretroviral therapy adherence. J Acquir Immune Defic Syndr. 2002, 31 (3): 128-131.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"852_CR17","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1111\/j.1468-1293.2009.00750.x","volume":"11","author":"P Cicconi","year":"2010","unstructured":"Cicconi P, Cozzi-Lepri A, Castagna A, Trecarichi EM, Antinori A, Gatti F, Cassola G, Sighinolfi L, Castelli P, d\u2019Arminio Monforte A, ICoNA Foundation Study Group: Insights into reasons for discontinuation according to year of starting first regimen of highly active antiretroviral therapy in a cohort of antiretroviral-na\u00efve patients. HIV Med. 2010, 11: 104-113. 10.1111\/j.1468-1293.2009.00750.x.","journal-title":"HIV Med"},{"key":"852_CR18","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3941\/jrcr.v4i7.452","volume":"4","author":"D Meerkotter","year":"2010","unstructured":"Meerkotter D: Gynaecomastia associated with highly active antiretroviral therapy (HAART). Radiology Case. 2010, 4: 34-40.","journal-title":"Radiology Case"},{"key":"852_CR19","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1179\/joc.2004.16.3.303","volume":"16","author":"R Manfredi","year":"2004","unstructured":"Manfredi R, Calza L, Chiodo F: True gynecomastia in congenitally HIV-infected children treated with antiretroviral agents. J Chemother. 2004, 16: 303-305.","journal-title":"J Chemother"},{"key":"852_CR20","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1097\/01.inf.0000200138.37519.5b","volume":"25","author":"A Dzwonek","year":"2006","unstructured":"Dzwonek A, Clapson M, Withey S, Bates A, Novelli V: Severe gynecomastia in an African boy with perinatally acquired human immunodeficiency virus infection receiving highly active antiretroviral therapy. Pediatr Infect Dis J. 2006, 25: 183-184. 10.1097\/01.inf.0000200138.37519.5b.","journal-title":"Pediatr Infect Dis J"},{"key":"852_CR21","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1097\/QAI.0b013e3182423668","volume":"59","author":"VJ Tukei","year":"2011","unstructured":"Tukei VJ, Asiimwe A, Maganda A, Atugonza R, Sebuliba I, Bakeera-Kitaka S, Musoke P, Kalyesubula I, Kekitiinwa A: Safety and tolerability of antiretroviral therapy among HIV-infected children and adolescents in Uganda. J Acquir Immune Defic Syndr. 2011, 59: 274-280.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"852_CR22","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1097\/00002030-200107270-00018","volume":"15","author":"JA Caso","year":"2001","unstructured":"Caso JA, Prieto J d M, Casas E, Sanz J: Gynecomastia without lipodystrophy syndrome in HIV-infected men treated with efavirenz. AIDS. 2001, 15: 1447-1448. 10.1097\/00002030-200107270-00018.","journal-title":"AIDS"},{"key":"852_CR23","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1097\/00002030-200101050-00021","volume":"15","author":"P Mercie","year":"2001","unstructured":"Mercie P, Viallard JF, Thi\u00e9baut R, Faure I, Rispal P, Leng B, Pellegrin JL: Efavirenz-associated breast hypertrophy in HIV-infection patients. AIDS. 2001, 15: 126-129. 10.1097\/00002030-200101050-00021.","journal-title":"AIDS"},{"key":"852_CR24","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1111\/j.1468-1293.2010.00831.x","volume":"11","author":"MJ Sikora","year":"2010","unstructured":"Sikora MJ, Rae JM, Johnson MD, Desta Z: Efavirenz directly modulates the oestrogen receptor and induces breast cancer cell growth. HIV Med. 2010, 11: 603-607. 10.1111\/j.1468-1293.2010.00831.x.","journal-title":"HIV Med"},{"key":"852_CR25","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1517\/17425250903483207","volume":"6","author":"NY Rakhmanina","year":"2010","unstructured":"Rakhmanina NY, van den Anker JN: Efavirenz in the therapy of HIV infection. Expert Opin Drug Metab Toxicol. 2010, 6: 95-103. 10.1517\/17425250903483207.","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"852_CR26","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s00238-010-0469-6","volume":"34","author":"IA Hoevenaren","year":"2011","unstructured":"Hoevenaren IA, Schott DA, Otten BJ, Kroese-Deutman HC: Prepubertal unilateral gynecomastia: a report of two cases. Eur J Plast Surg. 2011, 34: 395-398. 10.1007\/s00238-010-0469-6.","journal-title":"Eur J Plast Surg"},{"key":"852_CR27","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jadohealth.2007.03.010","volume":"41","author":"P Kumanov","year":"2007","unstructured":"Kumanov P, Deepinder F, Robeva R, Tomova A, Li J, Agarwal A: Relationship of adolescent gynecomastia with varicocele and somatometric parameters: a cross-sectional study in 6200 healthy boys. J Adolesc Health. 2007, 41: 126-131. 10.1016\/j.jadohealth.2007.03.010.","journal-title":"J Adolesc Health"},{"key":"852_CR28","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1097\/QAI.0b013e3181b327ca","volume":"52","author":"MS Shiels","year":"2009","unstructured":"Shiels MS, Cole SR, Kirk GD, Poole C: A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals. J Acquir Immune Defic Syndr. 2009, 52: 611-622. 10.1097\/QAI.0b013e3181b327ca.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"852_CR29","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1086\/650539","volume":"50","author":"JT Schouten","year":"2010","unstructured":"Schouten JT, Krambrink A, Ribaudo HJ, Kmack A, Webb N, Shikuma C, Kuritzkes DR, Gulick RM: Substitution of nevirapine because of efavirenz toxicity in AIDS clinical trials group A5095. Clin Infect Dis. 2010, 50: 787-791. 10.1086\/650539.","journal-title":"Clin Infect Dis"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2431-13-120.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2431-13-120\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2431-13-120","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2431-13-120.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T01:03:42Z","timestamp":1630544622000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/1471-2431-13-120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,13]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["852"],"URL":"https:\/\/doi.org\/10.1186\/1471-2431-13-120","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,13]]},"assertion":[{"value":"21 May 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"120"}}